在阿尔茨海默病中TET1介导表观遗传调制的作用
Matthew J Armstrong1, Yulin Jin1, Selina M Vattathil2
1Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Neurobiology of disease
|August 10, 2023
概括
这项研究将TET1基因变异和改变的DNA基甲基化与阿尔茨海默氏症 (AD) 病原发生联系起来. 在小鼠中,TET1功能的丧失加剧了AD病理,这表明TET酶是AD发展的关键.
科学领域:
- 神经科学是一个神经科学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 遗传学 是一个遗传学.
背景情况:
- 阿尔茨海默病 (AD) 涉及遗传,环境和表观遗传因素.
- 基因甲基化 (5mC) 和基甲基化 (5hmC) 调节基因表达.
- TET酶通过表观遗传修饰将环境因素与基因表达联系起来.
研究的目的:
- 研究TET1变异在早期阿尔茨海默病 (EOAD) 中的作用.
- 简介 5hmC 在AD脑组织中的变化.
- 使用小鼠模型检查Tet1损失对AD病变的影响.
主要方法:
- 在EOAD和对照队伍中对TET1进行有针对性的重新测序.
- 在人类死后脑组织中对5hmC的分析.
- 使用Tet1淘汰赛 (KO) 5xFAD小鼠模型进行神经病理和分子分析.
主要成果:
- 罕见的TET1变异在AD患者中显著丰富 (p=0.04).
- 在甲基组调节基因 (TET3,DNMT3L,DNMT3A,MECP2) 中确定了差异甲基化区域 (DhMR).
- 在5xFAD小鼠中,Tet1损失增加了粉样斑块负担 (p=0.044) 并改变了关键AD相关途径中的基因表达.
结论:
- TET酶,特别是TET1,在AD病变发生过程中发挥作用.
- 失去TET功能可能会加剧AD相关的神经病理.
- 甲基组调节者的表观遗传失调有助于AD的发展.
更多相关视频
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
9.7K
09:12Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
Published on: December 20, 2019
6.4K
相关概念视频
01:26Alzheimer's Disease: Overview
521
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
521
01:22Alzheimer's Disease: Treatment
215
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
215
01:37Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
02:25Spreading of Chromatin Modifications
8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.3K